Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1

被引:82
|
作者
Gorny, Miroslaw K. [1 ]
Wang, Xiao-Hong [3 ]
Williams, Constance [1 ]
Volsky, Barbara [1 ]
Revesz, Kathy [3 ]
Witover, Bradley [1 ]
Burda, Sherri [1 ]
Urbanski, Mateusz [1 ]
Nyambi, Phillipe [1 ,3 ]
Krachmarov, Chavdar [4 ]
Pinter, Abraham [4 ]
Zolla-Pazner, Susan [1 ,3 ]
Nadas, Arthur [2 ]
机构
[1] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA
[2] NYU, Sch Med, Inst Environm Med, New York, NY 10016 USA
[3] Vet Affairs New York Harbor Healthcare Syst, New York, NY 10010 USA
[4] Publ Hlth Res Inst, Newark, NJ 07103 USA
关键词
Immunoglobulin gene usage; Human monoclonal antibodies; Anti-HIV-1; antibodies; HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; EXTENSIVE SOMATIC MUTATION; POLYMERASE-CHAIN-REACTION; EQUATORIAL RAIN-FORESTS; MEMORY B-CELLS; MOLECULAR CHARACTERIZATION; TYPE-1; GP120; CORECEPTOR SELECTIVITY; ENVELOPE GLYCOPROTEIN;
D O I
10.1016/j.molimm.2008.09.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human anti-V3 monoclonal antibodies (mAbs) generated from HIV-1 infected individuals display diversity in the range of their cross-neutralization that may be related to their immunogenetic background. The study of the immunoglobulin (Ig) variable region gene usage of heavy chains have shown a preferential usage of the VH5-51 gene segment which was detected in 35% of 51 human anti-V3 mAbs. In contrast, human mAbs against other envelope regions of HIV-1 (anti-Env), including the CD4-binding domain, the CD4-induced epitope, and gp41 preferentially used the VH1-69 gene segment, and none of them used the VH5-51 gene, Furthermore, the usage of the VH4 family by anti-V3 mAbs was restricted to only one gene segment, VH4-59, while the VH3 gene family was used at a significantly lower frequency by all of the analyzed anti-HIV-1 mAbs. Multivariate analysis showed that usage of VH gene segments was significantly different between anti-V3 and anti-Env mAbs, and compared to antibodies from healthy subjects. In addition, the anti-V3 mAbs preferentially used the JH3 and D2-15 gene segments. The preferential usage of selected Ig gene segments and the characteristic pattern of Ig gene usage by anti-V3 mAbs can be related to the conserved structure of the V3 region. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:917 / 926
页数:10
相关论文
共 50 条
  • [21] Focusing the immune response on the V3 loop of HIV-1 gp120 induces cross-clade neutralizing
    Zolla-Pazner, Susan
    Sharpe-Cohen, Sandra
    Krachmarov, Chavdar
    Wang, Shixia
    Pinter, Abraham
    Lu, Shan
    RETROVIROLOGY, 2006, 3
  • [22] SYNERGISTIC NEUTRALIZATION OF HIV-1 BY HUMAN MONOCLONAL-ANTIBODIES AGAINST THE V3 LOOP AND THE CD4-BINDING SITE OF GP120
    TILLEY, SA
    HONNEN, WJ
    RACHO, ME
    CHOU, TC
    PINTER, A
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (04) : 461 - 467
  • [23] Focusing the immune response on the V3 loop of HIV-1 gp120 induces cross-clade neutralizing
    Susan Zolla-Pazner
    Sandra Sharpe-Cohen
    Chavdar Krachmarov
    Shixia Wang
    Abraham Pinter
    Shan Lu
    Retrovirology, 3 (Suppl 1)
  • [24] Epitope mapping, V-region DNA sequence, and neutralizing fab fragments of two monoclonal antibodies against the HIV-1 V3 loop
    Duarte, CA
    Perez, L
    Vazquez, J
    Duenas, M
    Vilarrubia, OL
    Navea, L
    Valdes, R
    Reyes, O
    Montero, M
    Ayala, M
    Gavilondo, J
    IMMUNOTECHNOLOGY, 1996, 2 (01): : 11 - 20
  • [25] CHARACTERIZATION OF THE SPECIFICITY OF THE HUMAN-ANTIBODY RESPONSE TO THE V3-NEUTRALIZATION DOMAIN OF HIV-1
    ZWART, G
    WOLFS, TFW
    VALK, M
    VANDERHOEK, L
    KUIKEN, CL
    GOUDSMIT, L
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (11) : 1897 - 1908
  • [26] SYNERGISTIC NEUTRALIZATION OF HIV-1 BY MONOCLONAL-ANTIBODIES DIRECTED AGAINST THE V2 DOMAIN, V3 LOOP, AND CD4-BINDING SITE OF GP120
    TILLEY, SA
    VIJHWARRIER, S
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 227 - 227
  • [27] Expression, Glycoform Characterization, and Antibody-Binding of HIV-1 V3 Glycopeptide Domain Fused with Human IgG1-Fc
    Yang, Qiang
    Li, Cishan
    Wei, Yadong
    Huang, Wei
    Wang, Lai-Xi
    BIOCONJUGATE CHEMISTRY, 2010, 21 (05) : 875 - 883
  • [28] CHIMERAS FROM A HUMAN RHINOVIRUS 14-HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) V3 LOOP SEROPREVALENCE LIBRARY INDUCE NEUTRALIZING RESPONSES AGAINST HIV-1
    RESNICK, DA
    SMITH, AD
    GEISLER, SC
    ZHANG, AQ
    ARNOLD, E
    ARNOLD, GF
    JOURNAL OF VIROLOGY, 1995, 69 (04) : 2406 - 2411
  • [29] An immunoassay with bovine serum albumin coupled peptides for the improved detection of anti V3 antibodies in HIV-1 positive human sera
    Gómez, CE
    López-Campistrous, AE
    Duarte, CA
    JOURNAL OF VIROLOGICAL METHODS, 1998, 71 (01) : 7 - 16
  • [30] DOES THE HIV-1 MANIPULATE IMMUNE NETWORK VIA GP120 IMMUNOGLOBULIN-LIKE DOMAIN INVOLVING V3 LOOP
    METLAS, R
    VELJKOVIC, V
    VACCINE, 1995, 13 (04) : 355 - 359